GEN News article highlights RNA-seq advances


Recently, GEN News ran an article by Dr. Richard Stein about some significant advances being made with RNA-seq solutions. Titled “If ‘Overall’ Underwhelms, Try RNA-Seq,” the article covers several compelling cases where RNA-seq technology is used and includes commentary with scientific leaders from each area. Stein details how researchers are using RNA-seq to investigate topics that range from oncology and embryo development to co-expression and microbiome. These studies push the boundaries of knowledge beyond what has previously been possible, paving the way for tangible results, including more effective therapies and a clearer understanding of how and why embryonic cells develop.

As part of this coverage, Stein writes about QIAGEN’s suite of bioinformatics tools that support RNA-seq research. He calls out the relevance of Ingenuity® Pathway Analysis™(IPA) and Biomedical Genomics Workbench®, and mentions our recent demonstration of the RNA-seq solution at the annual meeting of the American Association for Cancer Research (AACR) in New Orleans.

We really enjoyed the article for its news-filled view of how RNA-seq and IPA combine to further science, medicine and drug discovery. We’re always interested in learning how people are applying our solutions. If you’re using our RNA-seq solutions in new or meaningful ways, feel free to get in touch and tell us more. We’d love to hear from you!

Jean-Noel Billaud

Jean-Noel Billaud, Ph.D. is a Principal Scientist at QIAGEN Bioinformatics. Before joining QIAGEN Bioinformatics, Dr. Billaud joined Ingenuity Systems 2008 as staff scientist for the in silico research program in oncology and infectious diseases. Jean-Noel Billaud holds a Ph.D. in Blood Cell Biology from Paris VII, and has done his post-doctoral work at the Scripps Research Institute (San Diego, CA).

Your email address will not be published. Required fields are marked *